Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has informed BSE that its Board of Directors will meet on 2 February 2026 at 3:00 PM at the corporate office in New Delhi. The meeting will consider and approve the unaudited financial results along with the Limited Review Report for the quarter and nine months ended 31 December 2025. The trading window for insiders has already been closed and will remain closed until 4 February 2026, ahead of the results announcement. No financial figures or outcomes have been disclosed at this stage — this is purely a pre-results intimation filing.
Investors should note that actual Q3 and 9-month FY26 results are upcoming, which could move the stock. The name change from Advik Laboratories to MPS Pharmaa is also noteworthy for shareholders updating their records. Until numbers are released, no actionable insight on performance is available.